CSF PrP-amyloid seeding predicts clinical onset in inherited prion disease
In the authors' words
Silent proteopathic seed propagation is hypothesised to precede neurodegenerative disease, but direct evidence that it signals near-term clinical conversion in humans is lacking. In prion disease, a prototypic disorder of proteopathic seeding, cerebrospinal fluid (CSF) real-time quaking-induced conversion (RT-QuIC) offers a direct measure of prion protein amyloid seeding activity. We analysed longitudinal CSF RT-QuIC data from 94 PRNP E200K mutation carriers across international natural history cohorts to determine whether seeding status predicts clinical conversion. Eleven carriers developed inherited prion disease; all showed at least one positive RT-QuIC result before onset. First positivity appeared a median of 2.0 years prior to symptoms (IQR 1.3-3.3; range 0.2-4.8). Landmark analyses showed RT-QuIC positivity identified a markedly increased short-term conversion risk, whereas persistently asymptomatic carriers remained negative throughout follow-up. These findings establish CSF RT-QuIC positivity as a biomarker-defined state of incipient conversion in E200K carriers, informing risk stratification and preventive trial design.
In plain words AI summary
Researchers studied 94 people with a genetic mutation that causes inherited prion disease. Eleven of them developed the disease, and all had tested positive on a spinal fluid test before symptoms began. The first positive test appeared a median of 2.0 years before symptoms started. A positive test indicated a sharply higher short-term risk of developing the disease. People who stayed healthy remained negative on the test throughout the study.
Written by Kimi K2.5 using only the abstract above. Jev checked that every sentence is supported by the abstract sentences it cites, and removed any that were not. Point at a sentence to highlight its source.
Appeared: Thursday, November 5. medRxiv. Preprint, not yet peer-reviewed.